Raia Drogasil (BSP:RADL3) Other Stockholders Equity: R$2,661 Mil (As of Mar. 2026)


BSP:RADL3 Raia Drogasil SA BSP:RADL3
91 GF Score
Price R$18.77
GF Value R$29.99
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Raia Drogasil Other Stockholders Equity?

Raia Drogasil BSP:RADL3 +3.53% 91 Other Stockholders Equity is R$2,661 Mil as of Mar. 2026. GuruFocus rates BSP:RADL3 with a GF Score™ of 91/100 and a GF Value™ of R$29.99 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Raia Drogasil's Other Stockholders Equity for the quarter that ended in Mar. 2026 was R$2,661 Mil.

Raia Drogasil's quarterly Other Stockholders Equity increased from Sep. 2025 (R$2,482 Mil) to Dec. 2025 (R$2,676 Mil) but then declined from Dec. 2025 (R$2,676 Mil) to Mar. 2026 (R$2,661 Mil).

Raia Drogasil's annual Other Stockholders Equity increased from Dec. 2023 (R$1,956 Mil) to Dec. 2024 (R$2,558 Mil) and increased from Dec. 2024 (R$2,558 Mil) to Dec. 2025 (R$2,676 Mil).

Raia Drogasil Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Raia Drogasil's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Raia Drogasil Other Stockholders Equity Chart

Raia Drogasil Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,177.67 2,840.86 1,956.00 2,558.45 2,676.21

Raia Drogasil Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,544.11 2,487.33 2,481.59 2,676.21 2,661.00
BSP:RADL3
91GF Score
Raia Drogasil SA BSP:RADL3
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Raia Drogasil Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of R$2,661 Mil mean?
Raia Drogasil (BSP:RADL3) has a Other Stockholders Equity of R$2,661 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Raia Drogasil and its competitors.
Is Raia Drogasil's Other Stockholders Equity too high?
Raia Drogasil's current Other Stockholders Equity is R$2,661 Mil. Overall, Raia Drogasil has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Raia Drogasil's Other Stockholders Equity compare to competitors?
Raia Drogasil's Other Stockholders Equity of R$2,661 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Raia Drogasil and its competitors. Raia Drogasil's current Other Stockholders Equity is R$2,661 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Raia Drogasil stock overvalued right now?
Based on GuruFocus' analysis, Raia Drogasil (BSP:RADL3) is currently considered Significantly Undervalued. The stock's GF Value™ is R$29.99, compared to a current price of R$18.77 — trading 37.4% below its estimated fair value. The current Other Stockholders Equity is R$2,661 Mil. Raia Drogasil's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Raia Drogasil (BSP:RADL3), the current Other Stockholders Equity is R$2,661 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Raia Drogasil (BSP:RADL3) Overvalued in 2026?

Based on GuruFocus' analysis, Raia Drogasil stock appears to be undervalued. The current stock price of R$18.77 is trading 37.4% below its estimated GF Value™ of R$29.99. GuruFocus considers Raia Drogasil to be Significantly Undervalued.

Key valuation signals for BSP:RADL3:

  • Other Stockholders Equity: R$2,661 Mil
  • GF Value™: R$29.99 vs. price of R$18.77 (37.4% below fair value)
  • GF Score™: 91/100 with 3 warning signs

No single metric tells the full story. See the BSP:RADL3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Raia Drogasil Business Description

Other Exchanges RADLY:USA
Address Avenue Corifeu de Azevedo Marques, 3097 Butanta, Sao Paulo, SP, BRA, 05339-900
Raia Drogasil SA operates a chain of pharmacies in Brazil. The company is mainly engaged in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines. Its pharmacies mainly operate under the Drogasil and Raia brands.
91GF Score

Get the complete analysis for BSP:RADL3

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$18.77
Price
R$29.99
GF Value